Skip to main navigation Skip to search Skip to main content

Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations

Research output: Contribution to journalArticlepeer-review

Search results